BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/29/2021 11:12:00 AM | Browse: 593 | Download: 1064
 |
Received |
|
2021-03-22 10:52 |
|
Peer-Review Started |
|
2021-03-22 10:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-14 03:21 |
|
Revised |
|
2021-06-28 20:13 |
|
Second Decision |
|
2021-09-02 02:54 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-09-02 06:03 |
|
Articles in Press |
|
2021-09-02 06:03 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-27 00:36 |
|
Publish the Manuscript Online |
|
2021-09-29 11:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Laura Coto, Irati Mendia, Carolina Sousa, Julio César Bai and Angel Cebolla |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministerio de Ciencia e Innovación |
DI-16-08943 |
| Ministerio de Ciencia e Innovación |
DI-17-09627 |
|
| Corresponding Author |
Julio César Bai, MD, Professor, Department of Gastroenterology, Dr. Carlos Bonorino Udaondo Gastroenterology Hospital, Av. Caseros 2061, Buenos Aires 1264, Argentina. jbai@intramed.net |
| Key Words |
Celiac disease; Gluten-free diet; Gluten immunogenic peptides; Immunoassays; Stool; Urine |
| Core Tip |
A strict gluten-free diet (GFD) is the only available treatment for celiac disease. However, treatment adherence is difficult due to the ubiquitous nature of gluten, hurting patients’ quality of life. Despite several tests to evaluate GFD compliance, it has been proven to be invasive or inefficient. The determination of gluten immunogenic peptides (GIP) in stool and urine has been developed as a non-invasive, direct, and specific test for GFD monitoring. We herein summarized the current available literature meeting the clinical utility of GIP determination compared to the available tools in use. |
| Publish Date |
2021-09-29 11:12 |
| Citation |
Coto L, Mendia I, Sousa C, Bai JC, Cebolla A. Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: A systematic review. World J Gastroenterol 2021; 27(37): 6306-6321 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i37/6306.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i37.6306 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
